Advertisements


Acer Therapeutics reports Q2 EPS ($1.09), consensus (78c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 13th, 2019

Acer Therapeutics reports Q2 EPS ($1.09), consensus (78c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 13th, 2019

Acer Therapeutics reports Q1 EPS (79c), consensus (82c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 14th, 2019

Acer Therapeutics reports Q1 EPS (53c), consensus (69c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 14th, 2018

Acer Therapeutics reports Q2 EPS (64c), consensus (55c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 13th, 2018

Anchiano Therapeutics reports Q3 EPS (43c), consensus (18c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 15th, 2019

Aprea Therapeutics reports Q3 EPS ($5.29), consensus ($3.94)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 14th, 2019

Rubius Therapeutics reports Q3 EPS (59c), consensus (53c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 14th, 2019

Entasis Therapeutics reports Q3 EPS (27c), consensus (87c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 14th, 2019

BioXcel Therapeutics reports Q3 EPS (57c), consensus (65c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 14th, 2019

VBL Therapeutics reports Q3 EPS (14c), consensus (14c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 14th, 2019

Leap Therapeutics reports Q3 EPS (33c), consensus (33c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 14th, 2019

Fulcrum Therapeutics reports Q3 EPS (97c), consensus ($2.98)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 14th, 2019

Y-mAbs Therapeutics reports Q3 EPS (70c), consensus (55c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 13th, 2019

Millendo Therapeutics reports Q3 EPS (87c), consensus (83c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 13th, 2019

Magenta Therapeutics reports Q3 EPS (54c), consensus (54c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 13th, 2019

Applied Therapeutics reports Q3 EPS (63c), consensus (49c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 13th, 2019

Abeona Therapeutics reports Q3 EPS (35c), consensus (44c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2019

Iterum Therapeutics reports Q3 EPS ($2.15), consensus ($1.65)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2019

Unum Therapeutics reports Q3 EPS (39c), consensus (32c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2019

Nabriva Therapeutics reports Q3 EPS (90c), consensus (28c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2019